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Abstract
In this study, we used HIV-1 as a model to demonstrate a novel approach for receptor-independent cell entry of virus. The heavy chain
of an anti-HIV-1 gp120 antibody was engineered with endocytotic and transmembrane motifs from either the cation-independent mannose
6-phospate receptor or the low-density lipoprotein receptor. Flow cytometry and immunofluorescence studies showed that the chimeric
antibodies were expressed on the cell surface and can undergo rapid internalization. Furthermore, one of the chimeric antibodies was able
to bind and internalize HIV-1. Using a luciferase reporter HIV-1, we further showed that internalized viruses could undergo replication.
Therefore, we have demonstrated a proof-of-principle of a novel method that can be used to internalize virus into cells, without prior
knowledge of the cellular receptor for the virus. We propose that this approach would be particularly useful for studying viruses whose
cellular receptor(s) is not known.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Infections by human immunodeficiency virus type 1
(HIV-1) involve binding of the viral external envelope pro-
tein gp120 to cell-surface CD4 molecules followed by in-
teractions with a coreceptor which results in the fusion of
the viral and cellular membranes (D’Souza and Harden,
1996; Moore et al., 1997; Chan and Kim, 1998; Berger et
al., 1999). Since the envelope protein gp120 is expressed on
the surface of the virion and the infected cell, it is logical
that most of the neutralizing antibodies found in patients are
reactive to it and that it is the target of many vaccine
developments (Haynes, 1996; Burton, 1997; Sattentau et al.,
1999; Poignard et al., 2001). Moreover, anti-HIV-1 gp120
antibodies have been used as carriers to kill infected cells
with toxin/drugs/lymphocytes without affecting normal
cells (Pincus et al., 1989, 1996; Zarling et al., 1988). As in
the case of gp120-based vaccines, the specific and high-
affinity binding between antigen and antibody emphasizes
this potential.
HIV-1 uptake can be reconstituted in heterologous cell
lines by the coexpression of CD4 and the respective che-
mokine receptor (see D’Souza and Harden, 1996 for review
and citations), suggesting that cell-type- and species-spe-
cific infection may be largely determined by the expression
of cellular receptor(s) for the virus. This provides an oppor-
tunity to develop cell-based and/or small animal based sys-
tems for viral infection. However, for many viruses, the
cellular receptors are not fully characterized and no proper
cell-based systems are available and this may be an obstacle
to the understanding of these viruses. Here, we propose a
novel system that enables receptor-independent uptake of
virus into cells, and suggest that this can be used to establish
heterologous cell-based or small animal based models for
studying viruses. The first step involved the isolation of
cDNAs that encode the heavy and light chains of an anti-
body, which can bind strongly and specifically to the virus
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or viral envelope protein(s). The immunoglobulin heavy
chain can be engineered with membrane-anchoring motifs
such that the recombinant antibody can be expressed on the
cell surface. An endocytotic signal from a recycling cell-
surface receptor that constitutively clusters in coated pits
and undergoes rapid internalization (Goldstein et al., 1985;
Trowbridge, 1991) can be also be added to enable the
surface chimeric antibody to endocytose. As such, the virus
can bind to the cells and can be internalized via the endo-
cytotic pathway. To test this hypothesis, we utilized the
specific and high-affinity binding capacity of an anti-HIV-1
gp120 antibody for the viral envelope protein to develop a
strategy for CD4/coreceptors-independent HIV-1 uptake
into a human embryonic kidney cell line, HEK-293.
Results
Isolation of immunoglobulin genes for anti-HIV gp120
antibody
cDNAs that encode the immunoglobulin heavy (IgH)
and light (IgL) chains of the anti-HIV-1 gp120 was obtained
from the hybridoma 902 (Chesebro and Wehrly, 1988; Pin-
cus et al., 1989) by RT-PCR. The nucleotide sequences and
deduced amino acid sequences of the cloned cDNAs are
shown in Fig. 1 (first 400 base pairs inclusive of the variable
regions). N-terminal sequences of the mature heavy and
light chains secreted by the hybridoma are EVQLQQSGAE
and DIQMTQSSSY, respectively, as determined by Edman
sequencing. These sequences of the secreted antibody
matched amino acids 18–27 and 21–30, respectively, of the
IgH and IgL proteins encoded by the cDNAs, thus confirm-
ing that the correct immunoglobulin genes have been iso-
lated (Fig. 1).
Surface expression and internalization of chimeric
recombinant antibody
Transient transfection of anti-HIV-1 gp120 IgH and IgL
into 293T mammalian cells resulted in the secretion of
recombinant antibody into cell-culture medium as most of
the IgH and IgL proteins were detected in the culture me-
dium (Fig. 2A, lane 3).
Chimeric heavy chains, IgH-CI-MPR and IgH-
LDLR, were constructed by fusing the transmembrane
domain and the cytoplasmic tail of the cation-independent
mannose-6-phospate receptor (CI-MPR) (aa 2305–2492)
and the low-density lipoprotein receptor (LDLR) (aa 790 to
860) to the C-terminal of the full-length IgH cDNA, respec-
tively. As shown in Fig. 2A, transient expression of IgL
with either chimeric heavy chains resulted in the retention
of IgH and IgL proteins in the cells (lanes 8, 9), showing
that the transmembrane motifs prevented the secretion of
the recombinant chimeric antibodies. In addition, there is
proper association between the Ig proteins as capturing the
IgH from the cell lysate with protein A/G beads (which
binds to the constant region of the immunoglobulin heavy
chain) also pulled down the IgL (Fig. 2A, lanes 8 and 9,
bottom panel).
Stable clones of 293 cells expressing IgL alone (293-
IgL), IgL and IgH-CI-MPR (293-IgH-CI-MPR/IgL),
and IgL and IgH-LDLR (293-IgH-LDLR/IgL) were
isolated. The surface expression of each clone was de-
termined by FACS analysis and for each chimeric anti-
body, a clone that shows the highest level of expression
was used for further analysis. As shown in Fig. 2B, the
amount of antibodies expressed on the surface of the
293-IgH-CI-MPR/IgL clone is greater than that for 293-
IgH-LDLR/IgL clone.
To determine if the chimeric antibodies can undergo
internalization, a FITC-conjugated anti-mouse F(ab)2
Fig. 1. Partial sequences of anti-HIV-1 gp120 immunoglobulin genes.
Nucleotide sequences (first 400 base pairs) and deduced amino acid se-
quences of the immunoglobulin cDNAs isolated from hybridoma 902,
which expresses an anti-HIV-1 gp120 antibody. N-terminal peptide se-
quences of the mature proteins that are secreted by hybridoma 902 were
determined by Edman sequencing. The deduced amino acids that corre-
sponded to sequences obtained by Edman sequencing were underlined. (A)
Heavy chain variable region. (B) Light chain variable region.
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Fig. 2. Expression of wild-type and chimeric anti-HIV-1 gp120 antibodies. (A) Antibodies secreted into the medium (culture medium, lanes 2–5) or retained
intracellularly (cell lysate, lanes 6–9) after transient transfection of 293T cells with IgL and IgH cDNAs, were pulled down with protein A/G beads and
detected by Western blot analysis. The cells were transfected with full-length IgL and wild-type IgH or chimeric IgH containing transmembrane and
endocytotic motifs from CI-M6PR (IgH-CI-MPR) or LDLR (IgH-LDLR). Lane 1 showed the heavy and light chains secreted by the hybridoma 902. The
wild-type antibody was secreted into the culture medium (lane 3), while the chimeric antibodies were retained by the cells (lanes 8 and 9). (B) Expression
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antibody was overlaid onto the stable clones, 293-IgH-
CI-MPR/IgL and 293-IgH-LDLR/IgL, for 1 h at 37°C
to allow endocytosis to occur. Fig. 2C (top panel) showed
a large amount of total (surface and intracellular) anti-
mouse F(ab)2 antibodies bound to 293-IgH-CI-MPR/
IgL and 293-IgH-LDLR/IgL cells but not to the un-
transfected 293 cells. When an additional acid wash was
used to remove anti-mouse F(ab)2 antibody bound on the
surface, strong staining of punctuate cytoplasmic struc-
tures was observed in 293-IgH-CI-MPR/IgL and 293-
IgH-LDLR/IgL cells, suggesting that some of the anti-
mouse F(ab)2 antibodies have been internalized (Fig.
2C, bottom panel).
Recombinant antibody can bind HIV-1 in solution and on
the cell surface
The attenuated HIV-1 MC99IIIBTat-Rev, which can
only be propagated in CEM-TART cells that constitutively
express tat and rev, provided a safe source of high titer virus
(Chen et al., 1992). Western blot analysis showed that the
antibodies secreted by hybridoma 902 or by 293T cells
transfected with IgH and IgL cloned from hybridoma 902
are capable of immunoprecipitating HIV-1 MC99IIIBTat-
Rev (Fig. 3A).
Next, the stable clones were incubated with the virus,
followed by a FITC-conjugated anti-HIV-1 gp120 antibody,
and then fluorescence-activated cell sorting (FACS) analy-
sis was performed to determine the amount of virus bound
on the cell surface. As shown in Fig. 3B, HIV-1 bound to
the surfaces of 293-IgH-CI-MPR/IgL cells but not to 293-
IgH-LDLR/IgL or 293-IgL cells. The level of binding was
comparable to that obtained for CEM-TART cells (Fig. 3B),
which bind HIV-1 through CD4 receptors. Interestingly,
293-IgH-LDLR/IgL cells cannot bind HIV-1 despite being
able to bind anti-mouse F(ab)2 antibodies (Figs. 2B and C).
This may suggest that the IgH-LDLR/IgL recombinant
antibody is not flexible enough and hence is not accessible
to the bulkier viruses. 293 cells expressing a recombinant
antibody that uses the transmembrane domain of CD4 for
membrane anchoring could also bind the HIV-1 (data not
shown). Alternatively, the lower level of antibodies ex-
pressed on the surface of this clone may account for its
inability to bind HIV-1.
Surface-bound HIV-1 can be internalized
into 293-IgH-CI-MPR/IgL cells
To determine if surface-bound virus can be internalized,
the cells were incubated with HIV-1 for 4 h at 4°C, which
allows accumulation of virus on the cell surface, but is a
nonpermissive temperature for endocytosis. Cells were then
shifted to 37°C for various times to enable endocytosis and
the amount of virus remaining on the cell surface was
determined by FACS analysis. As shown in Fig. 4A, inter-
nalization of surface-bound HIV-1 into 293-IgH-CI-MPR/
IgL cells was almost completed after 4 min at 37°C. In the
presence of 0.45 M sucrose, which inhibits the formation of
clathrin-coated pits (Heuser and Anderson, 1980), the inter-
nalization was greatly inhibited (Fig. 4A).
To confirm the internalization using an independent ex-
periment, the cells were incubated with HIV-1 for 1 h at
37°C to allow binding and internalization. Then the cells
were washed and lysed and subjected to Western blot anal-
ysis to detect for HIV-1 gp120 protein. As shown in Fig. 4B,
HIV-1 bound to 293-IgH-CI-MPR/IgL cells, but not to
control 293-IgL cells (lanes 2 and 4). Consistent with the
rapid internalization observed above, a high level of virus
was internalized into the 293-IgH-CI-MPR/IgL cells as
HIV-1 gp120 protein was still detected in the cell lysate
after an acid wash to remove virus bound on the cell surface
(Fig. 4B, lane 5). Again, in the presence of hypertonic
sucrose, virus was found on the surface of the cells but not
intracellularly (Fig. 4B, lanes 6 and 7). The effect of sucrose
on cell viability was examined using the cell proliferation
reagent, WST-1 (Roche), and we found that sucrose is not
highly toxic to the cells as the cell viability in the presence
of 0.45 M sucrose (after 1 h at 37°C) was 80% compared
to that in the absence of sucrose. Similar results were ob-
served when antibodies against mature HIV-1 Gag proteins,
p17 matrix and p24 capsid, were used instead (Fig. 4B),
indicating that whole virions have been internalized and not
just soluble gp120 proteins.
Infection of cells expressing chimeric antibody by HIV-1
with luciferase reporter virus
The stable clones were infected with HXB2-NL-Luc
reporter virus, which contained a luciferase gene inserted
into the nef gene and the level of infection over a single
replication cycle can be determined by measuring the lucif-
of chimeric anti-HIV-1 gp120 antibodies on the surface of 293 stable clones were determined by FACS analysis. Profiles of the cells labeled with
FITC-conjugated anti-mouse (Fab’)2 antibody are represented by open histograms, while control populations not labeled with any antibody are represented
by solid histograms. The expression of antibodies on the cell surface is slightly higher for 293-IgH-CI-MPR/IgL cells than 293-IgH-LDLR/IgL cells, as
shown by the greater increase in fluorescence upon labeling with anti-mouse (Fab’)2 antibody. 293-IgL cells did not show any surface staining by anti-mouse
(Fab’)2 antibody. (C) Untransfected 293 cells and stable clones, 293-IgH-CI-MPR/IgL and 293-IgH-LDLR/IgL, were overlaid with FITC-conjugated
anti-mouse F(ab’)2 antibody for 1 h at 37°C. Total (surface and intracellular, top) staining of cells by anti-mouse F(ab’)2 antibody as well as staining of
punctuate cytoplasmic structures (after acid wash to remove surface bound anti-mouse F(ab’)2 antibody, bottom) were observed for IgH-CI-MPR/IgL and
IgH-LDLR/IgL cells, indicating that the chimeric antibodies can undergo internalization. No unspecific binding of anti-mouse F(ab’)2 antibody to
untransfected 293 cells was observed.
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erase activities in the lysates of infected cells (Connor et al.,
1995; He et al., 1995). This reporter virus contained two
frameshifts (5 Env and Vpr aa26), which render this clone
Env and Vpr. The mutation of Env ensures that after the
virus is internalized into the cells, it is only competent for a
single round of replication and the measured infectivity
Fig. 3. Binding of HIV-1 to recombinant anti-HIV-1 gp120 antibody in solution and on the cell surface. (A) Antibodies secreted into culture media by
hybridoma 902 or by 293T cells transiently transfected with IgL and IgH were captured onto protein A/G beads and used to immunoprecipitate HIV-1
MC99IIIBTat-Rev. Western blot analysis showed the presence of HIV-1 gp120 protein on the beads after immunoprecipitation with these antibodies (after
IP). No binding of virus was detected when culture medium from cells transfected with IgL only was used. (B) Binding of virus to the cell surfaces of 293-IgL,
293-IgH-CI-MPR/IgL, 293-IgH-LDLR/IgL, and control CEM-TART cells were determined by FACS analysis. Cells were incubated with HIV-1 for 4 h
at 4°C, followed by a FITC-conjugated anti-HIV-1 gp120 antibody for another 3 h at 4°C, and then the cells were subjected to FACS analysis. Profiles of
the cells exposed to virus, followed by incubation with a FITC-conjugated anti-HIV-1 gp120 antibody, are represented by open histograms, while control
populations not exposed to virus but incubated with the same FITC-conjugated anti-HIV-1 gp120 antibody are represented by solid histograms. HIV-1 bound
to the surface of 293-IgH-CI-MPR/IgL cells and control CEM-TART cells, but not to 293-IgL or 293-IgH-LDLR/IgL cells.
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would be in the absence of viral spread. The mutation in Vpr
is not likely to be important here as in cell-culture systems;
the Vpr protein generally does not affect viral replication
(see review by Gibbs and Desrosiers, 1993). This reporter
virus was useful in our studies because the high sensitivity
with which luciferase can be detected permits quantification
of infection in a single cycle of viral replication, and the
amount of luciferase activity in cells infected with this virus
reports directly the number of integrated proviruses and
their transcriptional activity. In addition, as infection is
detected only after expression of the reporter gene, input
virus bound on the cell surface but not internalized does not
contributed to the luciferase activity.
For this study, cotransfection of pNL4.3-Luc-R E (Con-
nor et al., 1995; He et al., 1995) and pHXB2env, which
encodes envelope glycoproteins from the HIV-1 IIIB strain
(Page et al., 1990), plasmids was used to generate HXB2-
NL-Luc reporter viruses. Representative results of one such
experiment showed that none of the stable clones (293-IgL,
293-IgH-CI-MPR/IgL, and 293-IgH-LDLR/IgL) could
be infected with the HXB2-NL-Luc reporter virus as there
were no significant luciferase activities in the cell lysates 3
days postinfection (Fig. 5A, columns 5, 8, and 11). How-
ever, CEMss, a CD4 T cell line (Foley et al., 1965; Nara
et al., 1987; Nara and Fischinger, 1988), that was infected in
the same experiment, showed high luciferase activities (Fig.
5A, column 2). In another set of experiments, the cells were
treated with phorbol-12-myristate-13-acetate (PMA), which
can activate the HIV-1 LTR via induction of NF-B binding
factors (Li et al., 1994), 48 h after infection and the lucif-
erase activities were determined another 24 h later. In this
case, the luciferase activity in infected 293-IgH-CI-MPR/
IgL cells was 6.4 higher than the readings in infected
293-IgL cells (as background control), showing that the
internalized viruses have undergone replication (Fig. 5A,
columns 6 and 9). When compared to the readings in in-
fected 293-IgH-CI-MPR/IgL cells without PMA stimula-
tion, there is an increase of 11.5 after PMA stimulation
(Fig. 5A, columns 8 and 9). For CEMss cells with PMA
stimulation, the lucierase activity is 13.4 greater than the
reading in similarly treated 293-IgL cells (Fig. 5A, columns
3 and 6) and 2.2 the readings for infected CEMss without
PMA stimulation (Fig. 5A, columns 2 and 3). No significant
increase in luciferase activity was observed in infected 293-
IgH-LDLR/IgL cells (1.3 the reading in 293-IgL cells)
even after PMA treatment (Fig. 5A, columns 6 and 12),
consistent with their inability to bind HIV-1 (Fig. 3B).
When comparing stable clones derived from the same pa-
rental cells (HEK-293), the luciferase activity in the infected
cells would be directly proportional to viral uptake, as the
regulation of viral replication after entry is the same. There-
fore, the replication of HXB2-NL-Luc reporter virus in
293-IgH-CI-MPR/IgL cells is consistent with the ability of
the cell-surface chimeric antibody (IgH-CI-MPR/IgL) to
bind and internalize HIV-1, and conversely, no replication
was observed in 293-IgH-LDLR/IgL cells which could not
bind HIV-1.
To determine the specificity of HIV-1 infection in 293-
IgH-CI-MPR/IgL cells, the experiments were repeated in
the presence of several agents that may be able to interfere
with the infection. First, infection of 293-IgH-CI-MPR/
IgL cells with the HXB2-NL-Luc reporter virus was effi-
ciently blocked when 0.3 M sucrose was used to inhibit the
viral entry (Fig. 5B). Second, no luciferase activities were
observed when excess anti-mouse immunoglobulins (20 g/
ml) or heat-inacitivated HIV-1 MC99IIIBTat-Rev were
used to compete with the HXB2-NL-Luc reporter virus for
internalization into 293-IgH-CI-MPR/IgL cells (Fig. 5B).
Last, when 293-IgH-CI-MPR/IgL cells were treated with
20 M 3 -azido-3-deoxythymidine (AZT) during and after
infection, the replication of the virus was also efficiently
inhibited (Fig. 5B). Determination of cell viability with
WST-1 showed that 20 M AZT was not toxic to the cell
over the course of the 3 day experiments (data not shown).
These agents also blocked the infection of CEMss cells to a
similar extent (Fig. 5C). A slightly lower sucrose concen-
tration was used for these infection experiments (0.3 M
instead of 0.45 M) than in the internalization experiments
described above because CEMss cells appeared to be more
sensitive to sucrose (data not shown).
Discussion
The rapid internalization of recycling cell-surface recep-
tors, that constitutively cluster in coated pits, is mediated by
structural features in their cytoplasmic domains (Goldstein
et al., 1985; Trowbridge, 1991). Furthermore, several stud-
ies have shown that “tyrosine internalization signals” are
self-determined structural motifs that could be transported
into proteins not normally endocytosed and would then
confer recycling properties to these molecules (Roth et al.,
1986; Ktistakis et al., 1990; Collawn et al., 1991).
In this study, we isolated cDNA for the immunoglobulin
heavy and light chains (Fig. 1) from a hybridoma that
produces an anti-HIV-1 gp120 antibody (Chesebro and
Wehrly, 1988; Pincus et al., 1989). The heavy chain is then
fused with the transmembrane and cytoplasmic domains of
two well-characterized recycling cell receptors, CI-MPR
and LDLR, respectively. When either chimeric heavy
chains, IgH-CI-MPR or IgH-LDLR, was cotransfected
with the light chain (IgL) into mammalian cells, the recom-
binant antibodies were expressed on the cell surface (Figs.
2A and B). As predicted, the endoctytotic signals in the
chimeric heavy chains allowed both chimeric antibodies to
undergo internalization (Fig. 2C).
We next demonstrated that attenuated HIV-1
MC99IIIBTat-Rev (Chen et al., 1992) can bind to the
surface of 293 cells stably expressing the chimeric antibody,
IgH-CI-MPR/IgL (293-IgH-CI-MPR/IgL) (Fig. 3B).
FACS analysis showed that HIV-1 bound on the surface of
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Fig. 4. Internalization of HIV-1 to 293 cells expressing chimeric antibody, IgH-CI-MPR/IgL. (A) To determine the rate of internalization of virus,
293-IgH-CI-MPR/IgL cells were first incubated with HIV-1 for 4 h at 4°C, washed, and then shifted to 37°C for different times to allow internalization
of the surface-bound virus. Upon incubation at 37°C, there was a rapid decrease in the percentage of virus remaining on the cell surface and almost all
surface-bound virus was internalized into 293-IgH-CI-MPR/IgL cells after 4 min. In the presence of 0.45 M sucrose, the percentage of virus remaining on
the cell surface was 80% after 4 min at 37°C. The values shown are the averages  S.D. of three independent experiments. (B) Cells were allowed to bind
and internalize HIV-1 at 37°C for 1 h, after which the cells were washed with PBS (PBS) or PBS and acid (Acid), before the amount of HIV-1 gp120 protein
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293-IgH-CI-MPR/IgL cells underwent rapid internaliza-
tion and the internalization could be inhibited by hypertonic
sucrose, suggesting the involvement of clathrin-coated pits
(Fig. 4A). HIV-1 internalized into 293-IgH-CI-MPR/IgL
cells could also be detected by Western blot analysis
(Fig. 4B).
Finally, significant luciferase activities were observed in
293-IgH-CI-MPR/IgL cells that were infected with a
HIV-1 IIIB pseudotyped luciferase reporter virus in the
presence of PMA (Fig. 5A), indicating that the internalized
viruses have undergone replication. However, no luciferase
activities were observed if the infections were performed in
the absence of PMA, suggesting that the replication of
HIV-1 in these cells need to be stimulated by PMA. Con-
sistently, no viral replication was observed in 293-IgL and
293-IgH-LDLR/IgL cells, which are not able to bind
HIV-1, even after PMA stimulation (Fig. 5A). In addition,
we demonstrated that the replication of HIV-1 in 293-IgH-
CI-MPR/IgL cells is specific, as no luciferase activity was
observed if there is blockage at the viral entry (with hyper-
tonic surcose or competition with excess anti-mouse immu-
noglobulin or heat-inactivated HIV-1 MC99IIIBTat-Rev
virus) or inhibition of replication postentry with an nucle-
oside-based inhibitor of HIV-1 reverse transcriptase, AZT
(Fig. 5B).
It is interesting to find that HIV-1 replication in 293-IgH-
CI-MPR/IgL cells was only observed after PMA stimula-
tion (12-fold increase when compared to unstimulated cells)
because a very similar observation has been reported for U1
cells, a cell line that was cloned from the chronically in-
fected promonocytic leukemic cell line U937 (Chen et al.,
1994). Infection of U1 cells with a luciferase-encoding
HIV-1 reporter showed that it is not able to support efficient
viral replication, suggesting that U1 cells lack some critical
factors for viral replication, or alternatively, express a re-
pressor of viral replication. However, PMA-phytohemag-
glutinin treatment of the infected U1 cells resulted in a
36-fold increase in the luciferase activity. Therefore, it ap-
pears that in both U1 and 293 cells, HIV-1 replication is
only supported upon the induction of NF-B binding factors
(for example, by PMA). For CEMss cells, stimulation with
PMA resulted in only a twofold increase in luciferase aci-
tivites and this is similar to that observed for U937 cells
(Chen et al., 1994), suggesting that viral replication is al-
ready near-maximum and thus, the effect of PMA stimula-
tion is less pronounced.
In summary, we have used chimeric anti-HIV-1 gp120
antibodies that were expressed on cell surfaces and were
capable of rapid internalization, to bind and internalize
HIV-1, resulting in the replication of HIV-1 in a previously
nonpermissive cell line. Collectively, our results serve as a
proof-of-principle that this novel approach can be used to
internalize viruses into cells in a receptor-independent man-
ner. It is noted that the anti-HIV-1 gp120 antibody produced
by the hybridoma 902 recognizes a very variable region of
HIV-1 gp120 (the V3 loop) and that it is specific for the IIIB
strain of HIV-1, and thus the system described here can only
internalize this particular strain of virus. Indeed, depending
on the requirements of the experiment, the specificity of
viral entry can be tailored by the selectivity of engineered
surface antibody for a particular virus strain or if the inter-
nalization of different virus strains is required, an antibody
that recognizes a conserved region on HIV-1 gp120 would
have to be used instead. In addition, this strategy for viral
uptake can be applied to any virus regardless of the actual
route of cell entry and can be used to modify antibodies
against viral envelope proteins, or cell-surface receptors that
are capable of binding the virus. In fact, we have recently
demonstrated that CD81 linked with endocytotic tags me-
diates the uptake of hepatitis C virus into cells (Tan et al.,
2003). By allowing rapid and efficient uptake of virus into
any type of cells, this strategy would be particularly useful
for studying virus when the cellular receptor is not known.
Furthermore, cell-surface display of functional antibod-
ies could be used to develop cells to harbor unique binding
and/or recycling property, for specific targeting or interac-
tion with another molecule on other cell types or for specific
uptake of defined macromolecules. As the internalized mac-
romolecules can be delivered to different endosomal com-
partments depending on the chosen transmembrane and
cytoplasmic domains, it will be possible to deliver the chi-
meric antibody and interacting virus or macromolecules to
defined cellular compartments.
Materials and methods
Cell lines
293, 293T, and HepG2 cells were purchased from Amer-
ican Type Cell Collection (Manassas, VA, USA). Cells
were cultured at 37°C in 5% CO2 in DMEM medium
containing 10% fetal bovine serum. CEMss cell was ob-
tained from the NIH AIDS Research and Reference Reagent
Program (catalog no. 776) and maintained in RPMI-160
medium supplemented with 10% fetal bovine serum.
(top) associated with the cells were determined by Western blot analysis. For 293-IgH-CI-MPR/IgL cells, the amount of internalized virus (Acid) was about
the same as the total (i.e., surface and intracellular) amount of virus associated with the cells (PBS) (lanes 4 and 5), indicating that most of viruses has been
internalized. In the presence of 0.45 M sucrose, the virus was bound on the surface but not internalized, as the acid wash efficiently removed the surface-bound
virus (lanes 6 and 7). No binding of virus to control 293-IgL cells was observed (lanes 2 and 3). Lane 1 showed the amount of HIV-1 gp120 protein in 1/20th
of the virus stock used. Expression of endogenous EF1- showed equal loading of total lysate.
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Fig. 5. Infection of stable 293 clones expressing chimeric antibodies with HIV-1 luciferase reporter. (A) HIV-1 reporter virus, bearing the luciferase indicator
gene in place of the nef gene and pseudotyped with a HIV-1 IIB envelope, was used to infect CEMss (columns 1–3), 293/IgL (columns 4–6),
293-IgH-CI-MPR/IgL (columns 7–9), and 293-IgH-LDLR/IgL (columns 10–12) cells. Induced luciferase enzyme activity is given in relative light units
measured in a luminometer and the luciferase activity is determined in duplicate for each cell. Each set of experiments is performed at least twice and a
representative result is shown here. White bars represented the readings for cells not exposed to virus; gray and black bars represented the readings for cells
exposed to virus in the absence and presence of phorbol 12-myristate 13-acetate (PMA), respectively. Infected 293-IgH-CI-MPR/IgL cells showed
significant increase in luciferase activity only in the presence of PMA (column 9). No significant luciferase activity was observed for 293-IgL or
293-IgH-LDLR/IgL cells infected in the absence or presence of PMA. (B) and (C) In an independent set of experiments, luciferase activities were measured
after 293-IgH-CI-MPR/IgL (B) or CEMss (C) cells were infected with the HIV-1 reporter virus in the absence of PMA, in the presence of PMA, in the
presence of PMA and 0.3 M sucrose, or 20 g/ml of anti-mouse immunoglobulin or heat-inactivated HIV-1 MC99IIIBTat-Rev or 20 M of AZT.
Background reading for uninfected cells was also determined.
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Isolation of anti-HIV-1 gp120 antibody heavy and light
chains cDNA
The hybridoma 902 (catalog no. 521) that produces an
anti-HIV-1LAV/HTLV-IIIB gp120 IgG1 monoclonal anti-
body was obtained from the NIH AIDS Research and Ref-
erence Reagent Program. Total RNA was extracted from the
hybridoma using RNeasy kit (Qiagen, Valencia, CA, USA)
and transcribed into cDNA using SuperscriptII RNase re-
verse transcriptase (Gibco-BRL, Gaithersburg, MD, USA).
PCR reaction was then carried out using the Expand long-
template PCR system from Roche Molecular Biochemicals
(Indianapolis, IN, USA) with the following primers:
For immunoglobulin light chain (IgL),
Forward: 5 ACCATGAAGTTTCCTTCTCAACT-
TCTGCTCTT 3
Reverse: 5 GCGCCGTCTAGAATTAACACTCAT-
TCCTGTTGAA 3
For immunoglobulin heavy chain (IgH), Forward: 5
GGGAATTCATGRAATGSASCTGGGTYWTY-
CTCTT 3 and 5 ACTAGTCGACATGGACTC-
CAGGCTCAATTTAGTTTTCCT 3
(R  A or G; Y  C or T; S  C or G; W  A or T)
Reverse: 5 TTATTTACCAGGAGAGTGGGAGA-
GGCTCTT 3. PCR products were cloned into
pCRII-TOPO vector using the TOPO TA cloning
kit (Invitrogen, Carlsbad, CA, USA).
Sequencing of cDNAs was performed with the Taq
DyeDeoxy terminator cycle sequencing kit and the
automated DNA sequencer 373 from Perkin–
Elmer Applied Biosystems (Foster City, CA,
USA).
Binding of antibody to protein A/G beads and Edman
peptide sequencing of heavy and light chains
Culture medium from the hybridoma or transfected cells
were incubated with protein A/G beads (Oncogene Re-
search Products, Cambridge, MA, USA) for 4 h at 4°C.
Then the beads were washed extensively with PBS, and the
bound proteins were eluted with Laemmli’s SDS buffer by
heating at 100°C for 5 min. For Edman sequencing of the
antibody secreted by the hybridoma, the bound proteins
were separated on a 15% SDS–polyacrylamide gel and then
transferred to PVDF membrane (Bio-Rad Laboratories,
Hercules, CA, USA). After the membrane was stained, two
major bands at 55 and 25 kDa were excised from the
membrane and processed for Edman sequencing on a Per-
kin–Elmer machine.
Cloning of IgL and IgH into expression vectors
IgL was cloned into NotI and KpnI sites of pXJ41neo
vector (Zheng et al., 1992) and IgH was cloned into KpnI
and HindIII sites of pCep4 vector (Invitrogen). The C-
terminal 187 amino acids of the human CI-MPR (GenBank
Accession No. J03528) and 71 amino acids of the human
LDLR (GenBank Accession No. L00352) were obtained by
RT-PCR using total cellular RNA from HepG2 cells as
described above. The primers used were as follows:
CI-MPRfor: 5 CCCAAGCTTGCAGTCGGCGCG-
GTGCTCAGC 3
CI-MPRrev: 5 ATAAGAATGCGGCCGCTCA-
GATGTGTAAGAGGTCCTCGTC 3
LDLRfor: 5 CCCAAGCTTCTGTCCATTGTCCTC-
CCCATC 3
LDLRrev: 5 ATAAGAATGCGGCCGCTCACGC-
CACGTCATCCTCCAG 3
The PCR products were then ligated into the 3 end of
pCep4-IgH using the HindIII and NotI sites, to give chi-
meric heavy chains.
Transfection of mammalian cells
Transient transfection experiments were performed using
Effectene reagent. To obtain stable clones, 20 g of pXJ-
neo-IgL DNA were mixed with about 5 106 293 cells and
electroporated at 0.25 kV using a gene pulser machine
(Bio-Rad). Cells were selected by growing in 0.4 mg/ml of
geneticin (Gibcd-BRL); single colonies were isolated and
total protein was analyzed by Western blot analysis. A
single clone that expressed a high level of IgL was then
transfected in the same manner with the respective chimeric
IgH constructs and cells were selected by growing in 0.2
mg/ml hygromycin B (Roche). Single colonies were iso-
lated and analyzed by Western blot analysis and flow cy-
tometry.
Western blot analysis
Cells were lysed in HBS buffer (10 mM HEPES, 150
mM NaCl, 1% NP-40) and total protein concentration was
determined by Coomassie Plus reagent from Pierce (Rock-
ford, IL, USA). Thirty micrograms 30-g of total cell lysate
was separated on SDS–polyacrylamide gel and transferred
to nitrocellulose membrane (Amersham International, UK).
Then, the membrane was blocked with 5% nonfat dry milk.
For the detection of IgL protein, the blot was incubated
overnight with a horseradish peroxidase (HRP) conjugated
anti-mouse light chain antibody from BD Pharmingen (San
Diego, CA, USA), followed by detection using an enhanced
chemiluminescence method (Pierce). For the heavy chain,
the blot was incubated with a HRP-conjugated goat anti-
mouse (Pierce) antibody for 1 h at room temperature before
detection.
To determine whether recombinant antibodies were se-
creted or retained by the cells, the culture medium and cell
lysate (in HBS buffer) of transfected cells were incubated
with protein A/G beads as described above and any associ-
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ated IgL and IgH chains were detected by Western blot
analysis.
Flow cytometry
To determine the expression of recombinant antibody on
the cell surface, cells were trypsinized, washed with PBS 
1% BSA, and resuspended at 0.5  106 cells/ml. Cells
(0.3 ml) were incubated with a goat anti-mouse F(ab’)2
antibody (15 g/ml) conjugated with FITC (Pierce) for 2 h
at 4°C, washed with cold PBS  1% BSA, and then ana-
lyzed by FACS on a Becton–Dickinson flow cytometer (San
Jose, CA, USA). At least 15,000 cells were counted for each
sample.
Immunofluorescence
Cells were plated onto poly-D-lysine (Sigma, St. Louis,
USA) -treated Permanox slide chambers (Nalge Nunc In-
ternational Corp., IL, USA) and allowed to settle overnight.
Then FITC-conjugated anti-mouse F(ab)2 antibody (7.5
g/ml) was overlaid onto the cells for 1 h at 37°C. The plate
was then cooled on ice for 5 min before any unbound
antibody was removed with three washes of cold PBS. For
stripping of surface-bound antibody, the cells were further
incubated with cold 0.2 M acetic acid/0.5 M NaCl (Haigler
et al., 1980) for 10 min, followed by PBS washes. Cells
were fixed with 3.7% formaldehyde for 10 min at room
temperature followed by PBS washes. Slides were mounted
and then analyzed on a MRC1024 laser confocal micro-
scope (Bio-Rad).
Virus propagation and binding experiments
The HIV-1 MC99IIIBTat-Rev (catalog no. 1943) and
CEM-TART cells (catalog no. 1944) were obtained from
the NIH AIDS Research and Reference Reagent Program.
Viruses were propagated as previously described (Chen et
al., 1992) and stored at 70°C. Production of viruses was
verified by subjecting the culture medium to Western blot
analysis using anti-HIV-1 p24 (NEN Life Science Products
Inc., Boston, MA, USA) and anti-HIV-1 gp120 (Biodesign
International, Saco, ME, USA) monoclonal antibodies.
Anti-HIV-1 p17 monoclonal antibody was also obtained
from Biodesign International.
For in vitro binding experiments, secreted antibodies
from hybridoma 902 were captured onto protein A/G as
described above and then incubated overnight with HIV-1
MC99IIIBTat-Rev. The beads were washed and any
bound virus was eluted by boiling the beads in Laemmli’s
SDS buffer and detected by Western blot analysis. Simi-
larly, recombinant antibody secreted into the culture me-
dium following transient transfection of 293T was tested for
its ability to bind HIV-1.
To determine the binding of HIV-1 on the cell surface,
cells were incubated with virus for 4 h at 4°C, followed by
cold PBS 1% BSA washes (3), and then incubated with
a FITC-conjugated anti-HIV-1 gp120 monoclonal antibody
for another 3 h at 4°C. Cells were washed again (3) and
FACS analysis was performed as described above. For time-
course studies, cells were incubated with virus for 4 h at 4°C
to allow the virus to bind to the surface receptors, and then
washed 2 with cold complete DMEM medium. Then, the
cells were resuspended in 0.3 ml of medium and incubated
at 37°C for various times to allow internalization of surface-
bound virus. Then, the cells were washed once with cold
PBS  1% BSA and the amount of virus remaining on the
cell surface was determined by FACS analysis as described
above. For treatment with hypertonic sucrose, 0.45 M su-
crose was included in all the steps, except for the incubation
of anti-HIV gp120 antibody and washes with PBS  1%
BSA. At each time point, the change in mean fluorescence,
i.e., the difference in mean fluorescence between cells ex-
posed and cell not exposed to virus (both samples were
incubated with FITC-conjugated anti-HIV gp120 antibody
before FACS analysis), was computed using the CellQuest
software (Becton–Dickinson). The percentage of virus re-
maining on the surface of 293 cells stably transfected with
IgL and IgH-CI-MPR (293-IgH-CI-MPR/IgL) was then
calculated as 100  [(change in mean fluorescence for
293-IgH-CI-MPR/IgL cells at time t)  (change in mean
fluorescence for control cells at time t)]/[(change in mean
fluorescence for 293-IgH-CI-MPR/IgL cells at time 0) 
(change in mean fluorescence for control cells at time 0)].
The control cells used were 293 cells stably transfected with
IgL only (293-IgL).
In a separate experiment, 3  105 cells were incubated
with virus, in the absence or presence of 0.45 M sucrose, for
1 h at 37°C. Then, the cells were washed 3 with PBS 
2% BSA, followed by 5 with PBS, before the cells were
lysed in Laemmli’s SDS buffer and subjected to Western
blot analysis to detect for HIV-1 gp120 protein. For another
set of cells, the cells were washed 3 with PBS 2% BSA,
2 with PBS, and followed by 10 min with cold 0.2 M
acetic acid/0.5 M NaCl and another 3 PBS washes. The
level of endogenous EF1- protein (polyclonal antibody
from Santa Cruz Biotechnology, Santa Cruz, CA, USA) was
used to ensure equal loading.
To determine if 0.45 M sucrose has any effect on the
viability of the 293-IgH-CI-MPR/IgL cells, approximately
100,000 cells per well were plated in a 24-well plate and
allowed to settle overnight. Next day, 0.5 ml of medium
with and without 0.45 M sucrose was then added to the cells
for 1 h at 37°C. After that, the cells were washed 2 with
medium without sucrose and WST-1 reagent (Roche, final
dilution 1:10) was added to each well. Experiments were
performed in triplicate and absorbance readings (wave-
length 430 nm and reference wavelength 590 nm) were
taken on a plate reader (TECAN Austria Ges. M. B. H.,
Salzburg, Austria) at 1 and 2 h after the addition of WST-1.
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HIV-1 replication assay
Luciferase reporter viruses pseudotyped with HIV-1 IIIB
envelope (HXB2-NL-Luc reporter virus) were generated in
293T cells by cotransfection of pNL4.3-Luc-RE (NIH
AIDS Research and Reference Reagent Program, catalog
no. 3418) and pHXB2env (NIH AIDS Research and Refer-
ence Reagent Program, catalog no. 1069) as previously
described (Connor et al., 1995; He et al., 1995). Virus was
collected from cell supernatant 3 days posttransfection,
quick-spun to remove cellular debris, and stored at 70°C.
Cells (1  105) were seeded in 60 mm dishes about 16 h
prior to infection. Virus stock (0.5 ml) was added to cells
and incubated at 37°C for 2 h. Cells were washed, added
with fresh complete media, and reincubated at 37°C for
another 72 h. For treatment with PMA, 1 M of PMA
(Sigma) was added to the cells at 48 h after infection. At
72 h, cells were harvested, washed, lysed, and measured for
luciferase activity using the luciferase assay kit from Pro-
mega (Madison, WI, USA). Total protein concentration was
also determined using Coomassie Plus reagent (Pierce) and
used to normalize the luciferase values obtained.
To examine the effects of different agents on the infec-
tion of the cells, another set of cells (293-IgH-CI-MPR/
IgL or CEMss) were infected with 0.4 ml of the HXB2-NL-
Luc reporter virus in a final volume of 1 ml. To determine
if sucrose has any effect on the infection, 0.3 M sucrose was
added to the cells for 30 min before the HXB2-NL-Luc
reporter virus was added. For competition with anti-mouse
IgG1 antibody (Sigma), 20 g/ml of this antibody was
added together with the HXB2-NL-Luc reporter virus to the
cells. In the case of HIV-1 MC99IIIBTat-Rev, 0.2 ml of
this virus was inactivated by heating at 70°C for 15 min and
then added together with the HXB2-NL-Luc reporter virus
to the cells. In the case of AZT, 20 M AZT (Sigma) was
added to the cells together with the HXB2-NL-Luc reporter
virus. In all these experiments, 0.4 ml of the HXB2-NL-Luc
reporter virus (from the same preparation) was diluted to a
final volume of 1 ml with the respective reagents and com-
plete DMEM medium and incubated with the cells for 8 h.
After that, the cells were washed and processed as described
above, except in the case of AZT, where 20 M AZT was
included in the medium at every subsequent step. The ef-
fects of AZT on cell viability was also determined using
WST-1 as described above.
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